Business Context and Reporting Period
This Form 8-K Current Report was filed by MacroGenics, Inc. (MGNX) on September 23, 2021. The filing addresses a corporate governance matter regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements.
Material Changes
The material change reported is the departure of Mr. Paulo Costa from the Board of Directors. Mr. Costa, who has served since June 2009, notified the Board that he will not stand for reelection upon the expiration of his current term at the 2022 Annual Meeting of Stockholders.
Outlook and Management Commentary
- Reason for Departure: Mr. Costa's decision is based on personal reasons and is not due to any disagreement with the Company or its management.
- Transition Plan: Mr. Costa will continue to serve as Chair of the Board and Chair of the Nominating and Governance Committee until the conclusion of the 2022 Annual Meeting.
- Guidance: No financial guidance or operational outlook is provided in this filing.
Key Facts for Investor Verification
- Mr. Paulo Costa will not seek reelection as a director at the 2022 Annual Meeting.
- Mr. Costa currently holds the positions of Chair of the Board and Chair of the Nominating and Governance Committee.
- The departure is voluntary and unrelated to any disputes with management.
- Mr. Costa will remain in his current roles until the 2022 Annual Meeting concludes.